Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$24.03 USD
+0.83 (3.58%)
Updated Jun 17, 2024 04:00 PM ET
After-Market: $24.04 +0.01 (0.04%) 6:48 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Myriad Genetics, Inc. [MYGN]
Reports for Purchase
Showing records 141 - 160 ( 243 total )
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Myriad Genetics, Inc.
Industry: Medical - Biomedical and Genetics
Announced positive results from its Phase 3 clinical trial for niraparib
Provider: G.RESEARCH, LLC
Analyst: WOJDA S